YAP1 and hepatoblastoma: Mouse models of hepatoblastoma have demonstrated that CTNNB1 point mutations, in combination with the YAP1 oncogene, result in a more differentiated tumor phenotype than that of CTNNB1 exon 3–deletion mutant [79].